Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Timothy Bishop

Showing results (71-80 of 231) with videos related to

Pageof 24
Sort By:
Human Molecular Genetics|March 31, 2022
Defining novel causal SNPs and linked phenotypes at melanoma-associated lociCarolina Castaneda-Garcia, Vivek Iyer, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survivalCaroline Conway, Angana Mitra, Rosalyn Jewell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United KingdomJulia A Newton-Bishop, Yu-Mei Chang, Mark M Iles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2025
Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization AnalysisElla Fryer, D Timothy Bishop, Peter T Campbell, et al.
International Journal of Cancer|October 18, 2002
After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer familiesMark A Jenkins, Laura Baglietto, Gillian S Dite, et al.
Oncogene|April 28, 2005
A mutation hotspot at the p14ARF splice siteMark Harland, Claire F Taylor, Philip A Chambers, et al.
The British Journal of Dermatology|December 18, 2021
Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohortsJulia Steinberg, Mark M Iles, Jin Yee Lee, et al.
Diabetes|November 7, 2015
Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in HumansAparna Pal, Thomas P Potjer, Soren K Thomsen, et al.
The Journal of Clinical Investigation|April 18, 2018
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomasJérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Cancer Research|September 17, 2010
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancerAnanya Choudhury, Louisa D Nelson, Mark T W Teo, et al.
Pageof 24

Showing results (71-80 of 231) with videos related to

Sort By:
Pageof 24
Human Molecular Genetics|March 31, 2022
Defining novel causal SNPs and linked phenotypes at melanoma-associated lociCarolina Castaneda-Garcia, Vivek Iyer, Jérémie Nsengimana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survivalCaroline Conway, Angana Mitra, Rosalyn Jewell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United KingdomJulia A Newton-Bishop, Yu-Mei Chang, Mark M Iles, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 14, 2025
Investigating the Causal Effect of Potential Therapeutic Agents for Colorectal Cancer Prevention: A Mendelian Randomization AnalysisElla Fryer, D Timothy Bishop, Peter T Campbell, et al.
International Journal of Cancer|October 18, 2002
After hMSH2 and hMLH1--what next? Analysis of three-generational, population-based, early-onset colorectal cancer familiesMark A Jenkins, Laura Baglietto, Gillian S Dite, et al.
Oncogene|April 28, 2005
A mutation hotspot at the p14ARF splice siteMark Harland, Claire F Taylor, Philip A Chambers, et al.
The British Journal of Dermatology|December 18, 2021
Independent evaluation of melanoma polygenic risk scores in UK and Australian prospective cohortsJulia Steinberg, Mark M Iles, Jin Yee Lee, et al.
Diabetes|November 7, 2015
Loss-of-Function Mutations in the Cell-Cycle Control Gene CDKN2A Impact on Glucose Homeostasis in HumansAparna Pal, Thomas P Potjer, Soren K Thomsen, et al.
The Journal of Clinical Investigation|April 18, 2018
β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomasJérémie Nsengimana, Jon Laye, Anastasia Filia, et al.
Cancer Research|September 17, 2010
MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancerAnanya Choudhury, Louisa D Nelson, Mark T W Teo, et al.
Pageof 24